TMCnet News
U.S. Patents Awarded to Inventors in Pennsylvania (May 17)(Targeted News Service Via Acquire Media NewsEdge) Targeted News Service Targeted News Service ALEXANDRIA, Va., May 17 -- The following federal patents were awarded to inventors in Pennsylvania. *** Google Assigned Patent ALEXANDRIA, Va., May 17 -- Google, Mountain View, Calif., has been assigned a patent (8,441,548) developed by Michael Christian Nechyba, Pittsburgh, and Michael Andrew Sipe, Pittsburgh, for a "facial image quality assessment." The abstract of the patent published by the U.S. Patent and Trademark Office states: "An example method includes capturing, by a camera of a mobile computing device, an image, determining whether the image includes a representation of at least a portion of a face, and, when the image includes the representation of at least the portion of the face, analyzing characteristics of the image. The characteristics include at least one of a tonal distribution of the image that is associated with a darkness-based mapping of a plurality of pixels of the image, and a plurality of spatial frequencies of the image that are associated with a visual transition between adjacent pixels of the image. The method further includes classifying, by the mobile computing device, a quality of the image based at least in part on the analyzed characteristics of the image." The patent application was filed on June 15, 2012 (13/524,745). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,441,548&OS=8,441,548&RS=8,441,548 Written by Satyaban Rath; edited by Hemanta Panigrahi. *** E Ink Assigned Patent ALEXANDRIA, Va., May 17 -- E Ink, Cambridge, Mass., has been assigned a patent (8,441,714) developed by four co-inventors for multi-color electrophoretic displays. The co-inventors are Richard J. Paolini Jr., Framingham, Mass., George G. Harris, Woburn, Mass., Jonathan D. Albert, Philadelphia, and Barrett Comiskey, Shanghai, China. The abstract of the patent published by the U.S. Patent and Trademark Office states: "A multi-color electrophoretic medium contains first, second and third species of particles, the particles having substantially non-overlapping electrophoretic mobilities and bring of three different colors. The particles are dispersed in a fluid having a fourth color. A method for driving such a display is also described." The patent application was filed on Oct. 3, 2011 (13/251,457). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,441,714&OS=8,441,714&RS=8,441,714 Written by Satyaban Rath; edited by Hemanta Panigrahi. *** Temple University Assigned Patent ALEXANDRIA, Va., May 17 -- Temple University, Philadelphia, has been assigned a patent (8,441,720) developed by Eric Borguet, Merion Station, Pa., and Oleksandr Isaienko, Elkins Park, Pa., for "methods and devices for generation of broadband pulsed radiation." The abstract of the patent published by the U.S. Patent and Trademark Office states: "Methods and apparatus for non-collinear optical parametric ampliffication (NOPA) are provided. Broadband phase matching is achieved with a non-collinear geometry and a divergent signal seed to provide bandwidth gain. A chirp may be introduced into the pump pulse such that the white light seed is amplified in a broad spectral region." The patent application was filed on Feb. 27, 2009 (12/865,013). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,441,720&OS=8,441,720&RS=8,441,720 Written by Satyaban Rath; edited by Hemanta Panigrahi. *** E Ink Assigned Patent ALEXANDRIA, Va., May 17 -- E Ink, Cambridge, Mass., has been assigned a patent (8,441,716) developed by Richard J. Paolini Jr., Framingham, Mass., Steven Joseph Battista, Dorchester, Mass., and Jonathan D. Albert, Philadelphia, for "electro-optic displays, and color filters for use therein." The abstract of the patent published by the U.S. Patent and Trademark Office states: "A process for producing a color electro-optic display uses an electro-optic sub-assembly comprising an electro-optic layer and a light-transmissive electrically-conductive layer. This sub-assembly is laminated to a backplane comprising a plurality of electrodes with the electro-optic layer disposed between the backplane and the electrically-conductive layer. A flowable material is placed over the sub-assembly and a color filter array is placed over the electrically-conductive layer and aligned with the electrodes of the backplane to form the color electro-optic display." The patent application was filed on Dec. 13, 2011 (13/324,536). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,441,716&OS=8,441,716&RS=8,441,716 Written by Satyaban Rath; edited by Hemanta Panigrahi. *** Agere Systems Assigned Patent ALEXANDRIA, Va., May 17 -- Agere Systems, Allentown, Pa., has been assigned a patent (8,442,212) developed by four co-inventors for a "continuous power transfer scheme for two-wire serial link." The co-inventors are Johannes G. Ransijn, Wyomissing Hills, Pa., Boris A. Bark, Middletown, N.J., James D. Yoder, Leoa, Pa., and Peter Kiss, Basking Ridge, N.J. The abstract of the patent published by the U.S. Patent and Trademark Office states: "The invention provides a single digital communication link between system-side and line-side circuitry in a DAA, capable both of carrying data signals and of transferring a substantial amount of power to the line-side circuitry. The invention comprises a system-side interface circuit, a line-side interface circuit, and an isolation barrier including a transformer. Each interface circuit is capable of connection to an upstream communication circuit (either line-side or system-side), from which it may receive data signals to be transmitted across the isolation barrier to the other interface circuit, and to which it may pass data signals received across the isolation barrier from the other interface circuit. The line-side interface circuit may further include a rectifier and a storage device." The patent application was filed on April 28, 2011 (13/096,080). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,442,212&OS=8,442,212&RS=8,442,212 Written by Arpi Sharma; edited by Anand Kumar. *** University of Pennsylvania, University of New Jersey Assigned Patent ALEXANDRIA, Va., May 17 -- The University of Pennsylvania, Philadelphia, and the University of New Jersey, New Brunswick, N.J., have been assigned a patent (8,442,285) developed by four co-inventors for a "combined feature ensemble mutual information image registration." The co-inventors are Anant Madabhushi, South Plainfield, N.J., Jonathan Chappelow, Belle Mead, N.J., Michael Feldman, Garnet Valley, Pa., and John E. Tomaszewski, Abington, Pa. The abstract of the patent published by the U.S. Patent and Trademark Office states: "This invention relates to medical image registration. Specifically, the invention relates to a combined feature ensemble mutual information (COFEMI) for robust inter-modal, inter-protocol image registration." The patent application was filed on April 1, 2008 (12/593,651). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,442,285&OS=8,442,285&RS=8,442,285 Written by Arpi Sharma; edited by Anand Kumar. *** Microsemi Semiconductor (U.S.) Assigned Patent ALEXANDRIA, Va., May 17 -- Microsemi Semiconductor (U.S.), Austin, Texas, has been assigned a patent (8,442,213) developed by Qiangsheng Charssen Ge, Macungie, Pa., for a "method and apparatus for shared positive protection." The abstract of the patent published by the U.S. Patent and Trademark Office states: "A line card includes a plurality of subscriber line interface circuits, a plurality of interface lines, and a first overvoltage protector. The subscriber line interface circuits each have a first input terminal operable to receive power at a first positive reference voltage. The interface lines are each coupled to one of the subscriber line interface circuits for interfacing with subscriber lines external to the line card. The first overvoltage protector is coupled to the interface lines and referenced to the first positive reference voltage to provide overvoltage protection responsive to a voltage on at least one of the interface lines exceeding the first positive reference voltage." The patent application was filed on Aug. 31, 2009 (12/550,782). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,442,213&OS=8,442,213&RS=8,442,213 Written by Arpi Sharma; edited by Anand Kumar. *** Comcast Cable Communications Assigned Patent ALEXANDRIA, Va., May 17 -- Comcast Cable Communications, Philadelphia, has been assigned a patent (8,442,205) developed by six co-inventors for a "data and call routing and forwarding." The co-inventors are Arvind Kaushal, Marlton, N.J., Jon Boone, Coatesville, Pa., Sohel Khan, Philadelphia, Louis Rubin, Ruskin, Fla., Brett Sherman, Philadelphia, and Jaime Jimenez, Tinton Falls, N.J. The abstract of the patent published by the U.S. Patent and Trademark Office states: "One or more aspects of the disclosure relate to various functions and processes related to routing of calls originating from other service providers. For example, a method includes receiving a request to route a call or a call session, such as a session initiation request, from a second service provider and proceeding to route the requested call or session through a call routing facility of the first service provider to a requested destination of the call. Routing the call through the call routing facility may include determining a service provider type and/or an origination number type for the call, determining routing information for the call using the type information, and causing routing of the call to a destination of the call based on the routing information. Further aspects of the disclosure relate to various functions and processes related to accessing routing data and/or information from a routing database." The patent application was filed on Oct. 27, 2010 (12/913,634). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,442,205&OS=8,442,205&RS=8,442,205 Written by Arpi Sharma; edited by Anand Kumar. *** Takeda Pharmaceuticals USA Assigned Patent for Methods for Concomitant Administration of Colchicine and a Second Active Agent ALEXANDRIA, Va., May 17 -- Takeda Pharmaceuticals USA, Deerfield, Ill., has been assigned a patent (8,440,721) developed by Matthew W. Davis, Erwinna, Pa., for "methods for concomitant administration of colchicine and a second active agent." The abstract of the patent published by the U.S. Patent and Trademark Office states: "Methods for concomitant administration of colchicine together with one or more second active agents, e.g., ketoconazole and ritonavir, are disclosed. Such methods reduce the dangers commonly associated with such concomitant administration and provide additional benefits. Methods of notifying health care practitioners and patients regarding appropriate dosing for concomitant administration of colchicine together with second active agents are also provided." The patent application was filed on July 18, 2011 (13/184,704). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=84,40,721.PN.&OS=PN/84,40,721&RS=PN/84,40,721 Written by Amal Ahmed; edited by Jaya Anand. *** Plextronics Assigned Patent ALEXANDRIA, Va., May 17 -- Plextronics, Pittsburgh, has been assigned a patent (8,440,785) developed by Christopher T. Brown, Pittsburgh, Chad Landis, Oakmont, Pa., and Elena E. Sheina, Pittsburgh, for "compositions, methods and polymers." The abstract of the patent published by the U.S. Patent and Trademark Office states: "A composition comprising a homopolymer or a copolymer comprising bithiophene units for use in, for example, low band gap materials including uses in organic photovoltaic active layers. The band gap and other properties can be engineered by polymerization methods including selection of monomer structure and ratio of monomer components. In addition, a dimer adapted for making alternating copolymers further comprising one first monomer moiety comprising at least one bithiophene moiety compound covalently linked to one second monomer moiety comprising a different bithiophene moiety or at least one moiety that is not a bithiophene. The composition can be copolymerized to form an alternating copolymer that can be further processed to form a polymeric film used in a printed organic electronic device. A series of novel copolymers are designed that would allow fabrication of materials with tailor made electronic and/or mechanical properties that can be easily manipulated through molecules chemical structure and potentially result in long term stability under ambient conditions that can be advantageous for use in organic electronics (e.g., OPVs, OLEDs, OFETs). Improved methods are disclosed for making monomers comprising a benzo[2,1-b:3,4-b']dithiophene moiety that are useful as electronics materials." The patent application was filed on June 30, 2010 (12/828,121). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=84,40,785.PN.&OS=PN/84,40,785&RS=PN/84,40,785 Written by Amal Ahmed; edited by Jaya Anand. *** Influmedix Assigned Patent ALEXANDRIA, Va., May 17 -- Influmedix, Radnor, Pa., has been assigned a patent (8,440,720) developed by Jizhou Wang, Eagleville, Pa., Xiaodong Fan, Center Valley, Pa., and Lidia Cristian, Princeton Junction, N.J., for "methods of use of antiviral compounds." The abstract of the patent published by the U.S. Patent and Trademark Office states: "The present invention relates, in part, to methods of treatment, prevention, and inhibition of viral disorders. In one aspect, the present invention relates to inhibition of the M2 proton channel of influenza viruses (e.g. influenza A virus) and other similar viroporins (e.g., VP24 of Ebola and Marburg viruses; and NS3 protein of Bluetongue). The present invention further relates, inter alia, to compounds which have been shown to possess antiviral activity, in particular, inhibiting the M2 proton channel of influenza viruses." The patent application was filed on Sept. 13, 2010 (12/881,038). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=84,40,720.PN.&OS=PN/84,40,720&RS=PN/84,40,720 Written by Amal Ahmed; edited by Jaya Anand. *** Anacor Pharmaceuticals Assigned Patent ALEXANDRIA, Va., May 17 -- Anacor Pharmaceuticals, Palo Alto, Calif., has been assigned a patent (8,440,642) developed by ten co-inventors for boron-containing small molecules. The co-inventors are Stephen J. Baker, Mountain View, Calif., Tsutomu Akama, Sunnyvale, Calif., Carolyn Bellinger-Kawahara, Redwood City, Calif., Vincent S. Hernandez, Watsonville, Calif., Karin M. Hold, Belmont, Calif., James J. Leyden, Malvern, Pa., Kirk Maples, San Jose, Calif., Jacob J. Plattner, Orinda, Calif., Virginia Sanders, San Francisco, and Yong-Kang Zhang, San Jose, Calif. The abstract of the patent published by the U.S. Patent and Trademark Office states: "This invention relates to compounds useful for treating fungal infections, more specifically topical treatment of onychomycosis and/or cutaneous fungal infections. This invention is directed to compounds that are active against fungi and have properties that allow the compound, when placed in contact with a patient, to reach the particular part of the skin, nail, hair, claw or hoof infected by the fungus. In particular the present compounds have physiochemical properties that facilitate penetration of the nail plate." The patent application was filed on Sept. 1, 2011 (13/224,252). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=84,40,642.PN.&OS=PN/84,40,642&RS=PN/84,40,642 Written by Amal Ahmed; edited by Jaya Anand. *** Lattice Semiconductor Assigned Patent ALEXANDRIA, Va., May 17 -- Lattice Semiconductor, Hillsboro, Ore., has been assigned a patent (8,441,292) developed by Phillip Johnson, Hellertown, Pa., Richard Booth, Riegelsville, Pa., and Paulius Mosinskis, Richlandtown, Pa., for a delaying data signals. The abstract of the patent published by the U.S. Patent and Trademark Office states: "In one embodiment, multiple (serializer/deserializer) SERDES channels are aligned by selectively slipping one or more of the incoming serial data streams one bit at a time prior to deserialization. Within each SERDES channel, a slip circuit slips the corresponding serial data stream by one bit (i.e., one unit interval (UI)) by extending the high portion of the duty cycle of a corresponding clock signal. The high portion of the clock signal is extended using a 3-to-1 mux that selects a fixed high signal, such as the high power supply rail, as an intermediate mux output signal whenever transitioning between two different applied clock signals that are offset from one another by one UI. In this way, the slip circuit avoids glitches that might otherwise result from switching directly between the two clock signals." The patent application was filed on June 11, 2010 (12/813,573). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=8,441,292.PN.&OS=PN/8,441,292&RS=PN/8,441,292 Written by Kusum Sangma; edited by Anand Kumar. *** LSI Assigned Patent ALEXANDRIA, Va., May 17 -- LSI, San Jose, Calif., has been assigned a patent (8,441,281) developed by four co-inventors for a "current-mode logic buffer with enhanced output swing." The co-inventors are Makeshwar Kothandaraman, Bangalore, India, Pankaj Kumar, Bangalore, India, Paul K. Hartley, Emmaus, Pa., and John Christopher Kriz, Palmerton, Pa. The abstract of the patent published by the U.S. Patent and Trademark Office states: "A differential buffer circuit having increased output voltage swing includes a differential input stage including at least first and second transistors, the first and second transistors being operative to receive first and second signals, respectively. The buffer circuit further includes a bias stage connected between the differential input stage and a first voltage source. The bias stage is operative to generate a quiescent current as a function of a third signal supplied to the bias stage. A load circuit is connected between a second voltage source and the differential input stage, first and second differential outputs of the buffer circuit being generated at a junction between the load circuit and the differential input stage. The load circuit includes first and second switching elements coupled with the first and second transistors, respectively. The first switching element is operative to electrically connect the first differential output to the second voltage source when the first transistor is turned off. The second switching element is operative to electrically connect the second differential output to the second voltage source when the second transistor is turned off." The patent application was filed on June 21, 2011 (13/165,500). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=8,441,281.PN.&OS=PN/8,441,281&RS=PN/8,441,281 Written by Kusum Sangma; edited by Anand Kumar. *** Saladax Biomedical Assigned Patent ALEXANDRIA, Va., May 17 -- Saladax Biomedical, Bethlehem, Pa., has been assigned a patent (8,440,796) developed by five co-inventors for "lenalidomide and thalidomide immunoassays." The co-inventors are Salvatore J. Salamone, Stockton, N.J., Jodi Blake Courtney, Doylestown, Pa., Alexander Volkov, Allentown, Pa., Howard Sard, Arlington, Mass., and Vishnumurthy Hegde, Chelmsford, Mass. The abstract of the patent published by the U.S. Patent and Trademark Office states: "Novel conjugates and immunogens derived from lenalidomide and antibodies generated by these immunogens are useful in immunoassays for the quantification and monitoring of thalidomide and lenalidomide in biological fluids." The patent application was filed on Nov. 23, 2011 (13/303,356). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=84,40,796.PN.&OS=PN/84,40,796&RS=PN/84,40,796 Written by Amal Ahmed; edited by Jaya Anand. *** Lexicon Pharmaceuticals Assigned Patent ALEXANDRIA, Va., May 17 -- Lexicon Pharmaceuticals, The Woodlands, Texas, has been assigned a patent (8,440,652) developed by ten co-inventors for "MST1 kinase inhibitors and methods of their use." The co-inventors are David John Augeri, Princeton, N.J., Jeffrey Thomas Bagdanoff, Martinez, Calif., Simon David Peter Baugh, Ringoes, N.J., Marianne Carlsen, Yardley, Pa., Kenneth Gordon Carson, Princeton, N.J., John Anthony Gilleran, Bridgewater, N.J., Wei He, Lawrenceville, N.J., Tamas Oravecz, The Woodlands, Texas, Konstantin Salojin, Conroe, Texas, and Leonard Sung, Hopewell, N.J. The abstract of the patent published by the U.S. Patent and Trademark Office states: "Compounds for the inhibition of mammalian Ste20-like kinase 1 (MST1) are disclosed, along with compositions comprising them and methods of their use in the treatment, management or prevention of an inflammatory or autoimmune diseases or disorders. Particular compounds are of the formula: ##STR00001##." The patent application was filed on March 2, 2012 (13/410,407). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=84,40,652.PN.&OS=PN/84,40,652&RS=PN/84,40,652 Written by Amal Ahmed; edited by Jaya Anand. *** PPG Industries Ohio Assigned Patent ALEXANDRIA, Va., May 17 -- PPG Industries Ohio, Cleveland, has been assigned a patent (8,440,746) developed by six co-inventors for a "one component epoxy structural adhesive composition prepared from renewable resources." The co-inventors are Shanti Swarup, Allegheny County, Pa., Masayuki Nakajima, Allegheny County, Pa., Umesh C. Desai, Allegheny County, Pa., Tien-Chieh Chao, Allegheny County, Pa., Charles M. Kania, Allegheny County, Pa., and Britt Minch, Lake County, Ohio. The abstract of the patent published by the U.S. Patent and Trademark Office states: "Curable, one-package, stable adhesive compositions are provided comprising: (a) a resin component comprising a polyepoxide, (b) a polyamine having at least two primary amine, secondary amine, and/or ketimine functional groups; and (c) a curing component comprising dicyandiamide and an accelerator. At least a portion of the polyepoxide in the resin component is reacted with carboxy-terminated butadiene acrylonitrile polymer. The accelerator comprises a reaction product comprising a renewable polyol, a diisocyanate, and a dialkyl monoamine containing alkyl groups with at least two carbon atoms each. The compositions are suitable for use as adhesive compositions over a wide temperature range." The patent application was filed on Dec. 2, 2010 (12/958,460). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=84,40,746.PN.&OS=PN/84,40,746&RS=PN/84,40,746 Written by Amal Ahmed; edited by Jaya Anand. *** Merck Sharp & Dohme Assigned Patent for Diphenyl Substituted Alkanes ALEXANDRIA, Va., May 17 -- Merck Sharp & Dohme, Rahway, N.J., has been assigned a patent (8,440,672) developed by eleven co-inventors for diphenyl substituted alkanes. The co-inventors are Anthony Ogawa, Mountainside, N.J., Feroze Ujjainwalla, Scotch Plains, N.J., Ellen K. Vande Bunte, Colts Neck, N.J., Lin Chu, Scotch Plains, N.J., Debra Ondeyka, Fanwood, N.J., Ihor Kopka, Hampton, N.J., Bing Li, Towaco, N.J., Hyun Ok, Colonia, N.J., Minal J. Patel, East Orange, N.J., Jinyou Xu, Scotch Plains, N.J., and Rosemary Sisco, Reading, Pa. The abstract of the patent published by the U.S. Patent and Trademark Office states: "The instant invention provides compounds of Formula I which are 5-lipoxygenase activating protein inhibitors. Compounds of Formula (I) are useful as anti-atherosclerotic, anti-asthmatic, anti-allergic, anti-inflammatory and cytoprotective agents. ##STR00001##." The patent application was filed on Aug. 29, 2007 (12/377,136). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=84,40,672.PN.&OS=PN/84,40,672&RS=PN/84,40,672 Written by Amal Ahmed; edited by Jaya Anand. *** Takeda Pharmaceuticals USA Assigned Patent ALEXANDRIA, Va., May 17 -- Takeda Pharmaceuticals USA, Deerfield, Ill., has been assigned a patent (8,440,722) developed by Matthew W. Davis, Erwinna, Pa., for "methods for concomitant administration of colchicine and a second active agent." The abstract of the patent published by the U.S. Patent and Trademark Office states: "Methods for concomitant administration of colchicine together with one or more second active agents, e.g., verapamil, are disclosed. Such methods reduce the dangers commonly associated with such concomitant administration and provide additional benefits. Methods of notifying health care practitioners and patients regarding appropriate dosing for concomitant administration of colchicine together with second active agents are also provided." The patent application was filed on April 24, 2012 (13/454,255). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=84,40,722.PN.&OS=PN/84,40,722&RS=PN/84,40,722 Written by Amal Ahmed; edited by Jaya Anand. *** Bayer MaterialScience Assigned Patent ALEXANDRIA, Va., May 17 -- Bayer MaterialScience, Pittsburgh, has been assigned a patent (8,440,747) developed by George Combs, McMurray, Pa., Nigel Barksby, Moon Township, Pa., and Jeffrey F. Dormish, Upper St. Clair, Pa., for "cold-pressed mats of lignocellulosic material having improved cold tack and a process for their production." The abstract of the patent published by the U.S. Patent and Trademark Office states: "Cold-pressed mats of lignocellulosic material having a Push Off Test extension equal to at least 85% of that of a mat made with a urea-formaldehyde resin are produced from a lignocellulosic material and binder system. These mats are produced at ambient temperature by separately adding each component of the binder system to the lignocellulosic material, blending the lignocellulosic material and binder system to coat the lignocellulosic material with the binder system, forming the coated lignocellulosic material into the desired form and applying pressure to the formed lignocellulosic material to obtain the desired thickness. The binder system includes: (i) at least one polyfunctional isocyanate and (ii) at least one aqueous dispersion of an adhesive or tackifier." The patent application was filed on Sept. 30, 2010 (12/894,259). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=84,40,747.PN.&OS=PN/84,40,747&RS=PN/84,40,747 Written by Amal Ahmed; edited by Jaya Anand. *** Vitae Pharmaceuticals Assigned Patent ALEXANDRIA, Va., May 17 -- Vitae Pharmaceuticals, Fort Washington, Pa., has been assigned a patent (8,440,658) developed by nine co-inventors for "cyclic urea inhibitors of 11.beta.-hydroxysteroid dehydrogenase 1." The co-inventors are David A. Claremon, Maple Glen, Pa., Linghang Zhuang, Chalfont, Pa., Colin M. Tice, Ambler, Pa., Yuanjie Ye, Ambler, Pa., Wei He, Audubon, Pa., Suresh B. Singh, Kendall Park, N.J., Zhenrong Xu, Chalfont, Pa., Salvacion Cacatian, Conshohocken, Pa., and Wei Zhao, Eagleville, Pa. The abstract of the patent published by the U.S. Patent and Trademark Office states: "Disclosed is a compound represented by Formula (I): ##STR00001## or a pharmaceutically acceptable salt, monohydrate, enantiomer or diastereomer thereof. Also disclosed are pharmaceutical compositions comprising the compound of Formula (I) or a pharmaceutically acceptable salt, monohydrate, enantiomer or diastereomer thereof and methods of inhibiting 11.beta.-HSD1 activity comprising the step of administering to a mammal in need of such treatment an effective amount of a compound of Formula (I), or a pharmaceutically acceptable salt, monohydrate, enantiomer or diastereomer thereof. Values for the variables in Formula (I) are defined herein." The patent application was filed on Dec. 10, 2008 (12/747,391). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=84,40,658.PN.&OS=PN/84,40,658&RS=PN/84,40,658 Written by Amal Ahmed; edited by Jaya Anand. *** Lutron Electronics Assigned Patent ALEXANDRIA, Va., May 17 -- Lutron Electronics, Coopersburg, Pa., has been assigned a patent (8,441,197) developed by Mark S. Taipale, Harleysville, Pa., Aaron Dobbins, Hopedale, Mass., and Mehmet Ozbek, Allentown, Pa., for a "method of striking a lamp in an electronic dimming ballast circuit." The abstract of the patent published by the U.S. Patent and Trademark Office states: "A method of striking a gas discharge lamp involves the steps of generating a high-frequency square-wave voltage having an operating frequency, generating a sinusoidal voltage from the high-frequency square-wave voltage, controlling the operating frequency to a low-end frequency, and increasing the amplitude of the sinusoidal voltage during successive pulse times and then decreasing the amplitude of the sinusoidal voltage towards the low-end amplitude at the end of each of the successive pulse times until the lamp has struck, where the length of each of the successive pulse times being greater than the length of the previous pulse time. A maximum amplitude of the sinusoidal voltage during each pulse time may be greater than a maximum amplitude of the sinusoidal voltage during the previous pulse time." The patent application was filed on April 4, 2011 (13/079,288). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=8,441,197.PN.&OS=PN/8,441,197&RS=PN/8,441,197 Written by Kusum Sangma; edited by Anand Kumar. *** BASF Assigned Patent ALEXANDRIA, Va., May 17 -- BASF, Florham Park, N.J., has been assigned a patent (8,440,857) developed by Michael Virnig, Tucson, Ariz., Jack Bender, Corona de Tucson, Ariz., and Louis Rebrovic, Clarion, Pa., for a "sulfonate- or sulfate-capped anti-misting agents." The abstract of the patent published by the U.S. Patent and Trademark Office states: "Sulfonate- or sulfate-capped, alkoxylated anti-misting agents having the structures: R((AO).sub.nX).sub.m((AO).sub.nH).sub.p and R.sup.3C(O)NH(CH.sub.2).sub.zN.sup.+(CH.sub.3).sub.2CH.sub.2CHR.sup.4CH.s- ub.2SO.sub.3.sup.-, and to methods of suppressing mist from electrolyte solutions by adding a mist-suppressing amount of one or more of said compounds to electrolyte solutions." The patent application was filed on Sept. 19, 2007 (11/857,473). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,440,857&OS=8,440,857&RS=8,440,857 Written by Arpi Sharma; edited by Anand Kumar. *** Lyondell Chemical Technology Assigned Patent ALEXANDRIA, Va., May 17 -- Lyondell Chemical Technology, Houston, has been assigned a patent (8,440,846) developed by four co-inventors for a direct epoxidation process. The co-inventors are Vu A. Dang, Bear, Del., Roger A. Grey, West Chester, Pa., Jay F. Miller, Chester Springs, Pa., and Beaven S. Mandimutsira, Wynnewood, Pa. The abstract of the patent published by the U.S. Patent and Trademark Office states: "The invention is a process for epoxidizing an olefin with hydrogen and oxygen in a solvent comprising acetonitrile in the presence of an quinone-acid salt and a catalyst comprising a titanium zeolite and a noble metal. The process results in higher productivity and improved selectivity to propylene oxide from hydrogen and oxygen, as compared to processes that use only a quinone." The patent application was filed on Sept. 30, 2010 (12/894,626). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,440,846&OS=8,440,846&RS=8,440,846 Written by Arpi Sharma; edited by Anand Kumar. *** Endo Pharmaceuticals Assigned Patent ALEXANDRIA, Va., May 17 -- Endo Pharmaceuticals, Chadds Ford, Pa., has been assigned a patent (8,440,662) developed by seven co-inventors for "substituted quinazoline and pyrido-pyrimidine derivatives." The co-inventors are Roger Astbury Smith, Chester Springs, Pa., Scott Kevin Thompson, Phoenixville, Pa., Subramanya Hosahalli, Bangalore, India, Mallesham Bejugam, Rastra, India, Srinivas Nanduri, Hyderabad, India, Sunil Kumar Panigrahi, Boudh, India, and Natarajan Mahalingam, Ariyalur, India. The abstract of the patent published by the U.S. Patent and Trademark Office states: "The present application provides novel substituted quinazoline and pyrido-pyrimidine compounds and pharmaceutically acceptable salts thereof. Also provided are methods for preparing these compounds. These compounds are useful in co-regulating PI3K and/or mTOR activity by administering a therapeutically effective amount of one or more of the compounds to a patient. By doing so, these compounds are effective in treating conditions associated with the dysregulation of the PI3K/AKT/mTOR pathway. Advantageously, these compounds perform as dual PI3K/mTOR inhibitors. A variety of conditions can be treated using these compounds and include diseases which are characterized by inflammation or abnormal cellular proliferation. In one embodiment, the disease is cancer." The patent application was filed on Oct. 31, 2011 (13/285,227). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=84,40,662.PN.&OS=PN/84,40,662&RS=PN/84,40,662 Written by Amal Ahmed; edited by Jaya Anand. *** Spectrum Pharmaceuticals Assigned Patent ALEXANDRIA, Va., May 17 -- Spectrum Pharmaceuticals, Irvine, Calif., has been assigned a patent (8,440,620) developed by Anil Gulati, Naperville, Ill., Guru Reddy, Irvine, Calif., and Luigi Lenaz, Newtown, Pa., for "methods, compositions and articles of manufacture for contributing to the treatment of cancers." The abstract of the patent published by the U.S. Patent and Trademark Office states: "Methods, compositions and articles of manufacture for contributing to the treatment of cancers, including solid tumors, are disclosed. The methods, compositions and articles of manufacture can utilize an endothelin B agonist (ET.sub.B) to enhance the delivery and resulting efficacy of a chemotherapeutic agent." The patent application was filed on Aug. 29, 2011 (13/220,358). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=84,40,620.PN.&OS=PN/84,40,620&RS=PN/84,40,620 Written by Amal Ahmed; edited by Jaya Anand. *** University of Pennsylvania Assigned Patent ALEXANDRIA, Va., May 17 -- The University of Pennsylvania, Philadelphia, has been assigned a patent (8,440,617) developed by Omaida C. Velazquez, Bryn Mawr, Pa., and Katherine A. Gallagher, Ellicott City, Md., for a "hyperbaric treatment in wound healing." The abstract of the patent published by the U.S. Patent and Trademark Office states: "This invention relates to methods for treating chronic dermal ulcers using hyperbaric treatment in combination with progenitor cells and chemokine homing factors. Specifically, the invention relates to treatment of chronic wounds resulting from diabetes mellitus using compositions comprising EPC and SDF-1A, under hyperbaric condition to accelerate wound healing." The patent application was filed on March 21, 2008 (12/532,422). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=84,40,617.PN.&OS=PN/84,40,617&RS=PN/84,40,617 Written by Amal Ahmed; edited by Jaya Anand. *** Fairchild Semiconductor Assigned Patent ALEXANDRIA, Va., May 17 -- Fairchild Semiconductor, South Portland, Maine, has been assigned a patent (8,441,069) developed by 11 co-inventors for a "structure and method for forming trench-gate field effect transistor with source plug." The co-inventors are Hamza Yilmaz, Saratoga, Calif., Daniel Calafut, San Jose, Calif., Christopher Boguslaw Kocon, Mountain Top, Pa., Steven P. Sapp, Santa Cruz, Calif., Dean E. Probst, West Jordan, Utah, Nathan L. Kraft, Pottsville, Pa., Thomas E. Grebs, Mountain Top, Pa., Rodney S. Ridley, Scarborough, Maine, Gary M. Dolny, Mountain Top, Pa., Bruce D. Marchant, Murray, Utah, and Joseph A. Yedinak, Mountain Top, Pa. The abstract of the patent published by the U.S. Patent and Trademark Office states: "A field effect transistor includes a gate trench extending into a semiconductor region. The gate trench has a recessed gate electrode disposed therein. A source region in the semiconductor region flanks each side of the gate trench. A conductive material fills an upper portion of the gate trench so as to make electrical contact with the source regions along upper sidewalls of the gate trench. The conductive material is insulated from the recessed gate electrode." The patent application was filed on Oct. 21, 2011 (13/279,085). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,441,069&OS=8,441,069&RS=8,441,069 Written by Arpi Sharma; edited by Anand Kumar. *** Siemens Industry Assigned Patent ALEXANDRIA, Va., May 17 -- Siemens Industry, Alpharetta, Ga., has been assigned a patent (8,441,147) developed by Peter Willard Hammond, Greensburg, Pa., for a "device and system for bypassing a power cell of a power supply." The abstract of the patent published by the U.S. Patent and Trademark Office states: "A bypass device for bypassing a power cell of a multi-cell device. The bypass device includes a stationary portion of a first set of contacts connected to at least first and second output terminals of a power cell, a magnetically latching solenoid that, when energized, moves a moving portion of the first set of contacts from a first position to a second position or from the second position to the first position, and at least one added insulating material positioned between the solenoid and the first set of contacts, and configured to allow a voltage between the magnetically latching solenoid and the first and second output terminals of the power cell to exceed a voltage between said output terminals." The patent application was filed on Aug. 17, 2010 (12/857,630). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,441,147&OS=8,441,147&RS=8,441,147 Written by Arpi Sharma; edited by Anand Kumar. *** General Electric Assigned Patent for Method and System for Rail Vehicle Power Distribution and Management ALEXANDRIA, Va., May 17 -- General Electric, Schenectady, N.Y., has been assigned a patent (8,441,143) developed by five co-inventors for a "method and system for rail vehicle power distribution and management." The co-inventors are Todd William Goodermuth, Melbourne, Fla., Wolfgang Daum, Erie, Pa., Mark Kraeling, Melbourne, Fla., Jared Klineman Cooper, Palm Bay, Fla., and Ning Zhang, Melbourne, Fla. The abstract of the patent published by the U.S. Patent and Trademark Office states: "A rail vehicle system and a method for managing distribution of power in the rail vehicle system are provided." The patent application was filed on July 21, 2010 (12/840,345). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,441,143&OS=8,441,143&RS=8,441,143 Written by Arpi Sharma; edited by Anand Kumar. For more information about Targeted News Service products and services, please contact: Myron Struck, editor, Targeted News Service LLC, Springfield, Va., 703/304-1897; [email protected]; http://targetednews.com. -1125266 (c) 2013 Targeted News Service |